Akero Therapeutics (AKRO)
(Delayed Data from NSDQ)
$21.07 USD
+0.77 (3.79%)
Updated May 15, 2024 04:00 PM ET
After-Market: $20.90 -0.17 (-0.81%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Earnings News For AKRO
-
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Akero Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Can Akero Therapeutics (AKRO) Run Higher on Strong Earnings Estimate Revisions?